The Journal of hand surgery · 2014
Thoracodorsal nerve transfer for elbow flexion reconstruction in infraclavicular brachial plexus injuries.
СтатьяVideo-Audio MediaНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Soldado Francisco, Ghizoni Marcos F, Bertelli Jayme
Аннотация
PURPOSE: To report the clinical results of thoracodorsal nerve (TDN) transfer to the biceps nerve for elbow flexion restoration in infraclavicular brachial plexus injuries.
METHODS: Five male patients, mean age 33 years and affected with infraclavicular brachial plexus injuries, underwent a direct coaptation of the TDN to the nerve to the biceps an average of 8 months after injury. The procedure included the transfer of a branch of the TDN to the musculocutaneous nerve in 2 patients.
RESULTS: All patients achieved M4 elbow flexion strength according to the British Medical Research Council scale at a mean follow-up of 22 months.
CONCLUSIONS: Direct TDN transfer seems to be a useful surgical procedure for restoring elbow flexion in patients with infraclavicular brachial plexus injuries.
TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
METHODS: Five male patients, mean age 33 years and affected with infraclavicular brachial plexus injuries, underwent a direct coaptation of the TDN to the nerve to the biceps an average of 8 months after injury. The procedure included the transfer of a branch of the TDN to the musculocutaneous nerve in 2 patients.
RESULTS: All patients achieved M4 elbow flexion strength according to the British Medical Research Council scale at a mean follow-up of 22 months.
CONCLUSIONS: Direct TDN transfer seems to be a useful surgical procedure for restoring elbow flexion in patients with infraclavicular brachial plexus injuries.
TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.